RXRX

RECURSION PHARMACEUTICALS IN

RXRX·75629V104·US·Common Stock·Healthcare - Biotechnology-Activist

RXRX (RECURSION PHARMACEUTICALS IN) is held by 154 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($184.6M), ARK Investment Management LLC ($151.7M), STATE STREET CORP ($127.4M). Net institutional sentiment: Mixed.

154
Holders
(12 Elite)
$1.2B
Total Value
58% (161)
Consensus
94 buying - 67 selling
13F: Insider & Congress: Updated regularly
RXRX

Smart Money Verdict

View all
Loading verdict
Held by 154 funds
12 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 7, 2026 · Activists Aug 7, 2026 · Congress none

InsiderHRHERSHBERG ROBERTExercise 25K shOct 6, 2026
InsiderHRHERSHBERG ROBERTSell $125KOct 6, 2026
InsiderBBBorgeson BlakeSell $242KOct 6, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
50.3M(+16.5%)$184.6M0.0%-34.19%
35
Increased
41.3M(+2.8%)$151.7M1.0%-61.05%
44
Increased
34.7M(+21.8%)$127.4M0.0%-37.79%
36
Increased
31.1M(+36.8%)$114.3M0.0%-3.08%
39
Decreased
23.5M(-0.8%)$86.2M0.1%-87.95%
0
Increased
22.8M(+2.3%)$83.6M0.0%-2.20%
30
Increased
13.8M(+12.6%)$50.7M0.0%-54.42%
33
Unchanged
13.6M$50M0.3%-48.82%
0
Increased
8.9M(+75.4%)$32.8M0.0%-28.14%
44
Increased
5.5M(+1.7%)$20.2M0.3%-64.51%
34
Increased
5.5M(+1.7%)$20.2M0.0%-61.73%
29
Increased
4.8M(+19.9%)$17.5M0.0%-59.55%
34
Increased
4.7M(+63.9%)$17.3M0.0%-4.97%
41
Increased
4.1M(+8.7%)$15.2M0.0%-56.73%
31
Decreased
3.9M(-35.4%)$14.4M0.0%-16.86%
0
Decreased
3.5M(-1.3%)$12.7M0.0%-2.12%
0
Decreased
3.4M(-17.5%)$12.3M0.0%-35.65%
0
Decreased
3.3M(-22.1%)$12.1M0.0%-41.19%
0
Increased
3M(+16.5%)$11.2M0.0%-27.50%
32
Increased
2.7M(+25.5%)$10.1M0.0%-38.16%
34

Showing 1-20 of 169

1 / 9
RXRXRXRXRECURSION PHARMACEUTICALS IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used